Stockreport

Translational Research in Oncology (TRIO) Initiates Phase I Study for MT-5111

Molecular Templates, Inc.  (MTEM) 
Last molecular templates, inc. earnings: 11/12 05:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.mtem.com/investor-relations
PDF EDMONTON, Alberta, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Translational Research in Oncology (TRIO), a global academic clinical research organization, today announced enrol [Read more]